Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 524519, 11 pages
http://dx.doi.org/10.1155/2015/524519
Research Article

Detection of Differentially Expressed MicroRNAs in Rheumatic Heart Disease: miR-1183 and miR-1299 as Potential Diagnostic Biomarkers

1Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang 315041, China
2Yinzhou Second Hospital, Ningbo, Zhejiang 315040, China
3Ningbo University School of Medicine, Ningbo, Zhejiang 315211, China

Received 18 June 2015; Revised 1 August 2015; Accepted 26 August 2015

Academic Editor: Francesco Di Raimondo

Copyright © 2015 Ni Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. P. M. van Empel, L. J. de Windt, and P. A. da Costa Martins, “Circulating miRNAs: reflecting or affecting cardiovascular disease,” Current Hypertension Reports, vol. 14, no. 6, pp. 498–509, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Egea, A. Schober, and C. Weber, “Circulating miRNAs: messengers on the move in cardiovascular disease,” Thrombosis and Haemostasis, vol. 108, no. 4, pp. 590–591, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Donzelli, S. Strano, and G. Blandino, “microRNAs: short non-coding bullets of gain of function mutant p53 proteins,” Oncoscience, vol. 1, pp. 427–433, 2014. View at Google Scholar
  4. J. Ellinger and S. C. Müller, “MicroRNAs: a novel non-invasive biomarker for patients with urological malignancies,” Current Pharmaceutical Biotechnology, vol. 15, no. 5, pp. 486–491, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Zhu, W. Pan, and Y. Qian, “MicroRNA in immunity and autoimmunity,” Journal of Molecular Medicine, vol. 91, no. 9, pp. 1039–1050, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Zibert, M. B. Løvendorf, T. Litman, J. Olsen, B. Kaczkowski, and L. Skov, “MicroRNAs and potential target interactions in psoriasis,” Journal of Dermatological Science, vol. 58, no. 3, pp. 177–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Li, Z. Xu, K. Wang, N. Wang, and M. Zhu, “Network analysis of microRNAs, genes and their regulation in human bladder cancer,” Biomedical Reports, vol. 1, pp. 918–924, 2013. View at Google Scholar
  8. V. De Guire, R. Robitaille, N. Tétreault et al., “Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges,” Clinical Biochemistry, vol. 46, no. 10-11, pp. 846–860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Van Roosbroeck, J. Pollet, and G. A. Calin, “miRNAs and long noncoding RNAs as biomarkers in human diseases,” Expert Review of Molecular Diagnostics, vol. 13, no. 2, pp. 183–204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. W. J. Hsieh, F.-M. Lin, H.-D. Huang, and H. Wang, “Investigating microRNA-target interaction-supported tissues in human cancer tissues based on miRNA and target gene expression profiling,” PLoS ONE, vol. 9, no. 4, Article ID e95697, 2014. View at Publisher · View at Google Scholar
  11. L. Vrba, J. L. Muñoz-Rodríguez, M. R. Stampfer, and B. W. Futscher, “miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer,” PLoS ONE, vol. 8, no. 1, Article ID e54398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Wang, J. Zhao, J. Huang, H. Tang, S. Yu, and Y. Chen, “The regulatory roles of miRNA and methylation on oncogene and tumor suppressor gene expression in pancreatic cancer cells,” Biochemical and Biophysical Research Communications, vol. 425, no. 1, pp. 51–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. W. Tong and J. Nemunaitis, “Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?” Cancer Gene Therapy, vol. 15, no. 6, pp. 341–355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Chen and D.-Z. Wang, “MicroRNAs in cardiovascular development,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 5, pp. 949–957, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Shah, M. Sharma, R. Kumar, K. N. Brahmadathan, V. J. Abraham, and R. Tandon, “Rheumatic heart disease: progress and challenges in India,” Indian Journal of Pediatrics, vol. 80, supplement 1, pp. S77–S86, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Toor and H. Vohra, “Immune responsiveness during disease progression from acute rheumatic fever to chronic rheumatic heart disease,” Microbes and Infection, vol. 14, no. 12, pp. 1111–1117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Zheng, L. Xu, L. Sun et al., “Comparison of the ventricle muscle proteome between patients with rheumatic heart disease and controls with mitral valve prolapse: HSP 60 may be a specific protein in RHD,” BioMed Research International, vol. 2014, Article ID 151726, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Guilherme, K. F. Köhler, and J. Kalil, “Rheumatic heart disease: mediation by complex immune events,” Advances in Clinical Chemistry, vol. 53, pp. 31–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Guilherme and J. Kalil, “Rheumatic heart disease: molecules involved in valve tissue inflammation leading to the autoimmune process and anti-S. pyogenes vaccine,” Frontiers in Immunology, vol. 4, article 352, 2013. View at Publisher · View at Google Scholar
  20. R. Bhardwaj, A. Kandoria, R. Marwah et al., “Prevalence of rheumatic fever and rheumatic heart disease in rural population of Himachal—a population based study,” Journal of Association of Physicians of India, vol. 60, no. 5, pp. 13–14, 2012. View at Google Scholar · View at Scopus
  21. P. Nordet, R. Lopez, A. Dueñas, and L. Sarmiento, “Prevention and control of rheumatic fever and rheumatic heart disease: the Cuban experience (1986-1996-2002),” Cardiovascular Journal of Africa, vol. 19, no. 3, pp. 135–140, 2008. View at Google Scholar · View at Scopus
  22. Y. Wang, X.-Y. Xue, Y.-X. Liu et al., “Pulmonary arterial hypertension and microRNAs—an ever-growing partnership,” Archives of Medical Research, vol. 44, no. 7, pp. 483–487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Courboulin, R. Paulin, N. J. Giguère et al., “Role for miR-204 in human pulmonary arterial hypertension,” The Journal of Experimental Medicine, vol. 208, no. 3, pp. 535–548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Millard-Bullock, “The rheumatic fever and rheumatic heart disease control programme—Jamaica,” The West Indian Medical Journal, vol. 61, no. 4, pp. 361–364, 2012. View at Google Scholar · View at Scopus
  25. A. E. Mirrakhimov, A. M. Ali, A. Barbaryan, and S. Prueksaritanond, “Human immunodeficiency virus and pulmonary arterial hypertension,” ISRN Cardiology, vol. 2013, Article ID 903454, 11 pages, 2013. View at Publisher · View at Google Scholar
  26. C. L. Bockmeyer, L. Maegel, S. Janciauskiene et al., “Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression,” The Journal of Heart and Lung Transplantation, vol. 31, no. 7, pp. 764–772, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Kim, Y. Kang, Y. Kojima et al., “An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension,” Nature Medicine, vol. 19, no. 1, pp. 74–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Podolska, B. Kaczkowski, T. Litman, M. Fredholm, and S. Cirera, “How the RNA isolation method can affect microRNA microarray results,” Acta Biochimica Polonica, vol. 58, no. 4, pp. 535–540, 2011. View at Google Scholar · View at Scopus
  29. L. Kong, J. Zhu, W. Han et al., “Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study,” Acta Diabetologica, vol. 48, no. 1, pp. 61–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Camarillo, M. Swerdel, and R. P. Hart, “Comparison of microarray and quantitative real-time PCR methods for measuring MicroRNA levels in MSC cultures,” Methods in Molecular Biology, vol. 698, pp. 419–429, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Callari, P. Tiberio, L. De Cecco et al., “Feasibility of circulating miRNA microarray analysis from archival plasma samples,” Analytical Biochemistry, vol. 437, no. 2, pp. 123–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Pan, A. K. Murashov, E. J. Stellwag, and B. Zhang, “Monitoring microRNA expression during embryonic stem-cell differentiation using quantitative real-time PCR (qRT-PCR),” Methods in Molecular Biology, vol. 650, pp. 213–224, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. L. R. P. Ferreira, A. F. Frade, R. H. B. Santos et al., “microRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy,” International Journal of Cardiology, vol. 175, no. 3, pp. 409–417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. T. S. Elton, M. Khan, and D. Terentyev, “MicroRNAs in cardiovascular disease,” F1000 Medicine Reports, vol. 3, no. 1, article 10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. A. da Costa Martins, S. Leptidis, K. Salic, and L. D. de Windt, “Microrna regulation in cardiovascular disease,” Current Drug Targets, vol. 11, no. 8, pp. 900–906, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Boštjančič, N. Zidar, D. Štajer, and D. Glavač, “MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction,” Cardiology, vol. 115, no. 3, pp. 163–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Huang and J. Li, “MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker,” Journal of Physiology and Biochemistry, vol. 71, no. 3, pp. 479–486, 2015. View at Publisher · View at Google Scholar
  38. J. Novák, P. Kružliak, J. Bienertová-Vaškü, O. Slabý, and M. Novák, “MicroRNA-206: a promising theranostic marker,” Theranostics, vol. 4, no. 2, pp. 119–133, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Zhou, T. Chen, and J. U. Raj, “MicroRNAs in pulmonary arterial hypertension,” American Journal of Respiratory Cell and Molecular Biology, vol. 52, no. 2, pp. 139–151, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Bienertova-Vasku, J. Novak, and A. Vasku, “MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment,” Journal of the American Society of Hypertension, vol. 9, no. 3, pp. 221–234, 2015. View at Publisher · View at Google Scholar
  41. J. Zhou, Y. Zhou, J. Cao, H. Zhang, and Y. Yu, “Distinctive microRNA profiles in the salivary glands of Haemaphysalis longicornis related to tick blood-feeding,” Experimental and Applied Acarology, vol. 59, no. 3, pp. 339–349, 2013. View at Publisher · View at Google Scholar
  42. M. Hu, L. Jian, L. Zhang et al., “Functional polymorphism in the EpCAM gene is associated with occurrence and advanced disease status of cervical cancer in Chinese population,” Molecular Biology Reports, vol. 39, no. 7, pp. 7303–7309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Della Vittoria Scarpati, F. Falcetta, C. Carlomagno et al., “A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 83, no. 4, pp. 1113–1119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Yang, Q. Kan, P. Zhang, X.-Q. Zhang, X.-G. Zhou, and X.-Y. Zhou, “Bioinformatic analysis of target gene prediction and related signaling pathways of miRNA-126,” Chinese Journal of Contemporary Pediatrics, vol. 15, no. 3, pp. 227–232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Zhao, F. Tian, Y. Yu et al., “miRNA-dysregulation associated with tenderness variation induced by acute stress in Angus cattle,” Journal of Animal Science and Biotechnology, vol. 3, no. 1, article 12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Zhang, A. Edwards, W. Fan, E. K. Flemington, and K. Zhang, “MiRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes,” PLoS ONE, vol. 7, no. 6, Article ID e40130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Juhila, T. Sipilä, K. Icay et al., “MicroRNA expression profiling reveals MiRNA families regulating specific biological pathways in mouse frontal cortex and hippocampus,” PLoS ONE, vol. 6, no. 6, Article ID e21495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. E. C. Lai, “miRNAs: Whys and wherefores of miRNA-mediated regulation,” Current Biology, vol. 15, no. 12, pp. R458–R460, 2005. View at Publisher · View at Google Scholar · View at Scopus